Efficacy and Safety of Inhaled CMS in Bronchiectasis Subjects With Chronic P. Aeruginosa Infection. (PROMIS-I)

PHASE3CompletedINTERVENTIONAL
Enrollment

377

Participants

Timeline

Start Date

June 6, 2017

Primary Completion Date

April 9, 2021

Study Completion Date

April 9, 2021

Conditions
Non Cystic Fibrosis Bronchiectasis
Interventions
DRUG

CMS

"1 MIU equivalent to 80 mg colistimethate sodium diluted in 1 mL saline solution 0.45%. Investigational Medicinal Product (IMP) glass vials were shrink wrapped in opaque white plastic and provided in boxes of 30 vials (two weeks of b.i.d dosing).~The 1 MIU/mL CMS/0.45% saline solution was transferred from the glass vial into a specific nebuliser system fitted with a 0.3 mL medication chamber, for administration by inhalation. This delivered a nominal dose of 0.3 MIU/24 mg CMS (\~10 mg CBA) from the device.~The first dose of the IMP was administered at the site under the supervision of the site staff and subjects were instructed how to prepare and self-administer the IMP at home via a specific nebuliser system, b.i.d (morning and evening) over a period of 12 months.~At least 10 minutes (min) before each administration, an inhaled short-acting bronchodilator (e.g., salbutamol /albuterol), supplied by the Sponsor, could be taken to improve tolerability."

OTHER

Placebo

1 ml saline solution 0.45%. the placebo was made up of identical empty glass vials to which the same saline diluent was added in exactly the same way as the reconstitution of the active treatment by injecting the diluent through the rubber stopper. The glass vials were shrink wrapped with opaque white plastic to maintain the blind.

Trial Locations (85)

1051

Zambon Investigative Site, Auckland

2025

Zambon Investigative Site, Auckland

2305

Zambon Investigative Site, New Lambton Heights

3004

Zambon Investigative Site, Melbourne

3204

Zambon Investigative Site, Hamilton West

4032

Zambon Investigative Site, Chermside

4101

Zambon Investigative Site, South Brisbane

4120

Zambon Investigative Site, Greenslopes

5000

Zambon Investigative Site, Adelaide

5042

Zambon Investigative Site, Adelaide

6163

Zambon Investigative Site, Spearwood

8011

Zambon Investigative Site, Christchurch

8800

Zambon Investigative Site, Roeselare

9000

Zambon Investigative Site, Ghent

9016

Zambon Investigative Site, Dunedin

9103

Zambon Investigative Site, Jerusalem

10043

Zambon Investigative Site, Orbassano

10717

Zambon Investigative Site, Berlin

11527

Zambon Investigative Site, Athens

14059

Zambon Investigative Site, Berlin

15006

Zambon Investigative Site, A Coruña

20122

Zambon Investigative Site, Milan

20900

Zambon Investigative Site, Monza

22767

Zambon Investigative Site, Hamburg

23538

Zambon Investigative Site, Lübeck

25100

Zambon Investigative Site, Brescia

25198

Zambon Investigative Site, Lleida

27100

Zambon Investigative Site, Pavia

28006

Zambon Investigative Site, Madrid

28046

Zambon Investigative Site, Madrid

28850

Zambon Investigative Site, Torrejón de Ardoz

30625

Zambon Investigative Site, Hanover

39008

Zambon Investigative Site, Santander

41071

Zambon Investigative Site, Seville

45239

Zambon Investigative Site, Essen

46014

Zambon Investigative Site, Valencia

46026

Zambon Investigative Site, Valencia

48149

Zambon Investigative Site, Münster

48960

Zambon Investigative Site, Usansolo

49100

Zambon Investigative Site, Petah Tikva

56124

Zambon Investigative Site, Pisa

60590

Zambon Investigative Site, Frankfurt am Main

60596

Zambon Investigative Site, Frankfurt am Main

70124

Zambon Investigative Site, Bari

70300

Zambon Investigative Site, Ẕerifin

71100

Zambon Investigative Site, Foggia

76100

Zambon Investigative Site, Rehovot

80336

Zambon Investigative Site, München

81241

Zambon Investigative Site, München

90127

Zambon Investigative Site, Palermo

90147

Zambon Investigative Site, Palermo

3436212

Zambon Investigative Site, Haifa

4428164

Zambon Investigative Site, Kfar Saba

NSW 2134

Zambon Investigative Site, Concord

VIC 3199

Zambon Investigative Site, Frankston

WA 6009

Zambon Investigative Site, Nedlands

NSW 2145

Zambon Investigative Site, Westmead

00161

Zambon Investigative Site, Roma

9713 GZ

Zambon Investigative Site, Groningen

3814-501

Zambon Investigative Site, Aveiro

4710-243

Zambon Investigative Site, Braga

3000-075

ZambonInvestigative Site, Coimbra

4835-044

Zambon Investigative Site, Guimarães

1649-035

Zambon Investigative site, Lisbon

2674-514

Zambon Investigative Site, Loures

4099-001

Zambon Investigative Site, Porto

4200-319

Zambon Investigative Site, Porto

4435-502

Zambon Investigative Site, Vila Nova de Gaia

08035

Zambon Investigative Site, Barcelona

08036

Zambon Investigative Site, Barcelona

08041

Zambon Investigative Site, Barcelona

CH-9007

Zambon Investigative Site, Sankt Gallen

CB23 3RE

Zambon Investigative Site, Cambridge

CF64 2XX

Zambon Investigative Site, Cardiff

DD1 9SY

Zambon Investigative site, Dundee

EAH16 4SA

Zambon Investigative Site, Edinburgh

ME7 5NY

Zambon Investigative Site, Gillingham

G31 2ER

Zambon Investigative Site, Glasgow

KY2 5AH

Zambon Investigative Site, Kirkcaldy

L14 3PE

Zambon Investigational site, Liverpool

SA14 8QF

Zambon Investigative Site, Llanelli

SW36NP

Zambon Investigative Site, London

M23 9LT

Zambon investigative Site, Manchester

NE7 7DN

Zambon Investigative Site, Newcastle upon Tyne

WR5 1DD

Zambon Investigative Site, Worcester

All Listed Sponsors
lead

Zambon SpA

INDUSTRY

NCT03093974 - Efficacy and Safety of Inhaled CMS in Bronchiectasis Subjects With Chronic P. Aeruginosa Infection. (PROMIS-I) | Biotech Hunter | Biotech Hunter